U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

Johnson & Johnson JNJ has one of the most diverse revenue streams in the industry within the pharmaceutical division called ...

In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...

Number 5: Leading biosimilar companies Sandoz, STADA Arzneimittel, and Samsung Bioepis report impressive Q1 2025 growth, driven by strong denosumab biosimilars and expanding portfolios. Number 4: ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) in Q1 CY2025, with sales flat year on year at $170.5 million.

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...